Background
Methods
Study cohort
Patient recruitment and survey
Statistical analysis
Results
Study recruitment
Demographics
Total N (%) | GC Requirement Policy | BRCA1/2 Testing | |||||
---|---|---|---|---|---|---|---|
Before N (%) | After N (%) | P-value | Tested N (%) | Not Tested N (%) | P-value | ||
Total | 1247 | 297 (23.8) | 940 (75.4) | n/a | 966 (77.5) | 271 (21.7) | n/a |
Gender (F) | 1227 (98.4) | 293 (98.3) | 934 (98.4) | 0.99 | 950 (98.3) | 267 (98.5) | 0.29 |
Ethnicity | |||||||
Caucasian | 1028 (82.4) | 250 (83.9) | 778 (82.0) | 0.27 | 801 (82.9) | 219 (80.8) | 0.26 |
Hispanic/Latino | 83 (6.7) | 13 (4.4) | 70 (7.4) | 58 (6.0) | 24 (8.9) | ||
Black or African American | 69 (5.5) | 18 (6.0) | 51 (5.4) | 54 (5.6) | 15 (5.5) | ||
Other | 64 (5.1) | 17 (5.7) | 47 (5.0) | 50 (5.2) | 13 (4.8) | ||
Age Range (years) | |||||||
18–35 | 165 (13.2) | 26 (8.7) | 139 (14.7) | 0.01 | 125 (12.9) | 36 (13.3) | 0.47 |
36–45 | 347 (27.8) | 78 (26.2) | 269 (28.4) | 269 (27.8) | 77 (28.4) | ||
46–55 | 412 (33.0) | 98 (32.9) | 314 (33.1) | 323 (33.4) | 87 (32.1) | ||
56+ | 318 (25.5) | 94 (31.5) | 224 (23.6) | 224 (25.6) | 68 (25.1) | ||
Household Income | |||||||
< $24,999 | 29 (2.3) | 8 (2.7) | 21 (2.2) | 0.88 | 15 (1.6) | 14 (5.2) | 0.011 |
$25,000–$49,999 | 149 (12.0) | 33 (11.1) | 116 (12.2) | 113 (11.7) | 35 (12.9) | ||
$50,000–$99,999 | 395 (31.7) | 100 (33.6) | 295 (31.1) | 309 (32) | 83 (30.6) | ||
$100,000+ | 622 (49.9) | 146 (49.0) | 476 (50.2) | 493 (51) | 125 (46.1) | ||
Missing/Declined | 52 (4.2) | 11 (3.7) | 41 (4.3) | 36 (3.7) | 14 (5.2) | ||
Personal History | |||||||
Any Breast Cancer | 347 (27.8) | 93 (31.2) | 254 (26.8) | 0.14 | 307 (31.8) | 38 (14) | < 0.0001 |
Any Ovarian Cancer | 29 (2.3) | 5 (1.7) | 24 (2.5) | 0.40 | 24 (2.5) | 5 (1.8) | 0.53 |
Any Other Cancer | 52 (4.2) | 14 (4.7) | 38 (4.0) | 0.60 | 37 (3.8) | 14 (5.2) | 0.34 |
Cancer Free | 824 (66.1) | 191 (64.1) | 633 (66.7) | 0.41 | 601 (62.2) | 217 (80.1) | < 0.0001 |
Family History | |||||||
Any Breast Cancer | 504 (40.4) | 120 (40.3) | 384 (4.0) | 0.95 | 383 (39.6) | 118 (43.5) | 0.25 |
Ovarian Cancer | 97 (7.8) | 26 (8.7) | 71 (7.5) | 0.48 | 84 (8.7) | 12 (4.4) | 0.014 |
Any Other Cancer | 222 (17.8) | 45 (15.1) | 177 (18.7) | 0.16 | 150 (15.5) | 71 (26.2) | < 0.0001 |
Cancer Free | 367 (29.4) | 92 (30.9) | 27 (29.0) | 0.53 | 294 (30.4) | 71 (26.2) | 0.17 |
BRCA1/2 Test Requester | |||||||
Any Doctor | 891 (71.5) | 193 (64.8) | 698 (73.6) | 0.0034 | 693 (71.7) | 189 (69.7) | 0.52 |
Any Patient | 392 (31.4) | 120 (40.3) | 272 (28.7) | 0.0002 | 309 (32) | 81 (29.9) | 0.51 |
Any Neither | 17 (1.4) | 6 (2.0) | 11 (1.2) | 0.26 | 3 (0.3) | 14 (5.2) | < 0.0001 |
Any Other | 41 (3.3) | 11 (3.7) | 30 (3.2) | 0.65 | 34 (3.5) | 7 (2.6) | 0.43 |
Top Reasons for Pursuing BRCA1/2 Testing | |||||||
To determine risks for family members | 605 (48.5) | 146 (49.0) | 459 (48.4) | 0.85 | 474 (49.1) | 126 (46.5) | 0.45 |
To help plan cancer screening | 491 (39.4) | 117 (39.3) | 374 (39.4) | 0.96 | 367 (38) | 118 (43.5) | 0.10 |
To help plan cancer treatment | 205 (16.4) | 48 (16.1) | 157 (16.5) | 0.86 | 190 (19.7) | 13 (4.8) | < 0.0001 |
Because mutations are a common cause of breast cancer | 148 (11.9) | 27 (9.1) | 121 (12.8) | 0.09 | 126 (13) | 19 (7.0) | 0.004 |
Decisional conflict
GC Requirement Policy | BRCA1/2 Testing | ||||||
---|---|---|---|---|---|---|---|
Total N (%) | Before N (%) | After N (%) | P-value | Tested N (%) | Not Tested N (%) | P-value | |
This decision was hard for me | |||||||
Strongly Disagree (0 points) | 509 (40.8%) | 127 (42.6%) | 382 (40.3%) | 0.17 | 439 (47.7%) | 70 (31%) | < 0.0001 |
Disagree (1) | 365 (29.3%) | 90 (30.2%) | 275 (29.0%) | 285 (31%) | 80 (35.4%) | ||
Neither Disagree nor Agree (2) | 105 (8.4%) | 17 (5.7%) | 88 (9.3%) | 71 (7.7%) | 34 (15%) | ||
Agree (3) | 127 (10.2%) | 28 (9.4%) | 99 (10.4%) | 96 (10.4%) | 31 (13.7%) | ||
Strongly Agree (4) | 31 (2.5%) | 7 (2.4%) | 24 (2.5%) | 23 (2.5%) | 8 (3.5%) | ||
Do Not Know | 9 (0.7%) | 5 (1.7%) | 4 (0.4%) | 6 (0.7%) | 3 (1.3%) | ||
Missing/declined | 101 (8.1%) | 24 (8.1%) | 77 (8.1%) | 46 (4.8%) | 45 (16.6%) | ||
Mean Score (SD) | 0.93 (1.10) | 0.83 (1.05) | 0.96 (1.11) | 0.11 | 0.86 (1.08) | 1.22 (1.14) | < 0.0001 |
I was unsure what to do in this decision | |||||||
Strongly Disagree (0 points) | 479 (38.4%) | 119 (39.9%) | 360 (37.9%) | 0.24 | 424 (46.2%) | 55 (24.7%) | < 0.0001 |
Disagree (1) | 402 (32.2%) | 98 (32.9%) | 304 (32.0%) | 323 (35.2%) | 79 (35.4%) | ||
Neither Disagree nor Agree (2) | 113 (9.1%) | 20 (6.7%) | 93 (9.8%) | 75 (8.2%) | 38 (17%) | ||
Agree (3) | 105 (8.4%) | 27 (9.1%) | 78 (8.2%) | 66 (7.2%) | 39 (17.5%) | ||
Strongly Agree (4) | 25 (2.0%) | 2 (0.7%) | 23 (2.4%) | 19 (2.1%) | 6 (2.7%) | ||
Do Not Know | 16 (1.3%) | 6 (2.0%) | 10 (1.1%) | 10 (1.1%) | 6 (2.7%) | ||
Missing/declined | 107 (8.6%) | 26 (8.7%) | 81 (8.5%) | 49 (5.1%) | 48 (17.7%) | ||
Mean Score (SD) | 0.91 (1.03) | 0.81 (0.96) | 0.93 (1.05) | 0.08 | 0.80 (0.98) | 1.36 (1.12) | < 0.0001 |
I was aware of the choices I had in this decision | |||||||
Strongly Disagree (4 points) | 35 (2.8%) | 8 (2.7%) | 27 (2.9%) | 0.04 | 24 (2.6%) | 11 (4.9%) | < 0.0001 |
Disagree (3) | 38 (3.1%) | 11 (3.7%) | 27 (2.9%) | 21 (2.3%) | 17 (7.6%) | ||
Neither Disagree nor Agree (2) | 82 (6.6%) | 28 (9.4%) | 54 (5.7%) | 57 (6.2%) | 25 (11.1%) | ||
Agree (1) | 485 (38.9%) | 111 (37.3%) | 374 (39.4%) | 368 (40.3%) | 117 (52%) | ||
Strongly Agree (0) | 483 (38.7%) | 108 (36.2%) | 375 (39.5%) | 434 (47.5%) | 49 (21.8%) | ||
Do Not Know | 15 (1.2%) | 8 (2.7%) | 7 (0.7%) | 9 (1%) | 6 (2.7%) | ||
Missing/declined | 109 (8.7%) | 24 (8.1%) | 85 (9.0%) | 53 (5.5%) | 46 (17.0%) | ||
Mean Score (SD) | 0.78 (0.91) | 0.81 (0.91) | 0.77 (0.92) | 0.50 | 0.69 (0.88) | 1.16 (0.98) | < 0.0001 |
I needed more advice and information about the choices | |||||||
Strongly Disagree (0 points) | 301 (24.1%) | 71 (23.8%) | 230 (24.2%) | 0.22 | 264 (28.8%) | 37 (16.6%) | < 0.0001 |
Disagree (1) | 378 (30.3%) | 88 (29.5%) | 290 (30.6%) | 318 (34.7%) | 60 (26.9%) | ||
Neither Disagree nor Agree (2) | 254 (20.4%) | 62 (20.8%) | 192 (20.2%) | 197 (21.5%) | 57 (25.6%) | ||
Agree (3) | 129 (10.3%) | 31 (10.4%) | 98 (10.3%) | 87 (9.5%) | 42 (18.8%) | ||
Strongly Agree (4) | 57 (4.6%) | 11 (3.7%) | 46 (4.9%) | 39 (4.3%) | 18 (8.1%) | ||
Do Not Know | 20 (1.6%) | 10 (3.4%) | 10 (1.1%) | 11 (1.2%) | 9 (4%) | ||
Missing/declined | 108 (8.7%) | 25 (8.4%) | 83 (8.7%) | 50 (5.2%) | 48 (17.7%) | ||
Mean Score (SD) | 1.31 (1.12) | 1.28 (1.10) | 1.32 (1.13) | 0.64 | 1.23 (1.10) | 1.66 (1.16) | < 0.0001 |
I feel I made an informed choice | |||||||
Strongly Disagree (4 points) | 21 (1.7%) | 6 (2.0%) | 15 (1.6%) | 0.47 | 14 (1.5%) | 7 (3.1%) | < 0.0001 |
Disagree (3) | 24 (1.9%) | 6 (2.0%) | 18 (1.9%) | 11 (1.2%) | 13 (5.8%) | ||
Neither Disagree nor Agree (2) | 1 (0.1%) | 0 (0.0%) | 1 (0.1%) | 45 (4.9%) | 51 (22.7%) | ||
Agree (1) | 386 (31.0%) | 93 (31.2%) | 293 (30.9%) | 290 (31.7%) | 96 (42.7%) | ||
Strongly Agree (0) | 596 (47.8%) | 135 (45.3%) | 461 (48.6%) | 550 (60%) | 46 (20.4%) | ||
Do Not Know | 18 (1.4%) | 8 (2.7%) | 10 (1.1%) | 6 (0.7%) | 12 (5.3%) | ||
Missing/declined | 106 (8.5%) | 23 (7.7%) | 83 (8.7%) | 50 (5.2%) | 46 (17.0%) | ||
Mean Score (SD) | 0.64 (0.85) | 0.67 (0.88) | 0.62 (0.85) | 0.42 | 0.50 (0.78) | 1.22 (0.94) | < 0.0001 |
Decisional Conflict Scorea, mean (SD) | 22.8 (18.2) | 22.1 (18.0) | 23.0 (18.3) | 0.46 | 20.5 (17.1) | 33.0 (19.5) | < 0.0001 |
Adjusted Decisional Conflict Score, mean (SE)b | 22.5 (17.3) | 22.0 (1.31) | 22.6 (0.79) | 0.16 | 20.3 (0.69) | 32.7 (1.36) | < 0.0001 |
BRCA1/2 testing
GC Requirement Policy | ||||
---|---|---|---|---|
Total N (%) | Before N (%) | After N (%) | P-value | |
BRCA1/2 Testing Completion | n = 1247 | n = 297 | n = 940 | |
Yes | 966 (77.5%) | 243 (81.5%) | 723 (76.2%) | 0.13 |
No | 271 (21.7%) | 54 (18.1%) | 217 (22.9%) | |
Unknown/Missing/Declined | 10 (0.8%) | 1 (0.3%) | 9 (1%) | |
BRCA1/2 Test Results | n = 966 | n = 243 | n = 723 | |
Mutation | 89 (9.2%) | 26 (10.7%) | 63 (8.7%) | 0.55 |
No Mutation | 821 (85.0%) | 204 (84.0%) | 615 (85.3%) | |
Results Uncertain | 19 (2.0%) | 6 (2.5%) | 13 (1.8%) | |
Do not Understand Results | 8 (0.8%) | 0 (0.0%) | 8 (1.1%) | |
Unknown | 8 (0.8%) | 2 (0.8%) | 6 (0.8%) | |
Missing/Declined | 21 (2.2%) | 5 (2.1%) | 16 (2.2%) | |
Most commonly reported use of genetic testing resultsa | n = 966 | n = 243 | n = 723 | |
Talked with Family Members about Results | 590 (47.3%) | 147 (60.5%) | 443 (61.3%) | 0.42 |
Routine Breast Cancer Screenings | 329 (26.4%) | 71 (29.2%) | 258 (35.7%) | 0.25 |
Plan Cancer Treatment | 173 (13.9%) | 42 (17.3%) | 131 (18.1%) | 0.90 |
Additional Breast Cancer Screening with MRI utilized | 53 (4.3%) | 10 (4.1%) | 43 (6.0%) | 0.38 |
Surgery to Remove Breast or Ovaries to prevent Cancer | 40 (3.2%) | 11 (4.5%) | 29 (4.0%) | 0.59 |
Other | 39 (3.1%) | 17 (7.0%) | 22 (3.0%) | 0.003 |
Most commonly reported reasons for why BRCA1/2 testing was not completeda | n = 271 | n = 54 | n = 217 | |
Insurance issues/requirements | 165 (60.9%) | 39 (72.2%) | 126 (58.1%) | 0.06 |
Costs | 129 (47.6%) | 38 (70.4%) | 91 (41.9%) | 0.0002 |
Testing not recommended by GC | 56 (20.7%) | 3 (5.6%) | 53 (24.4%) | 0.002 |
Testing recommended for another family member | 24 (8.9%) | 4 (7.4%) | 20 (9.2%) | 0.79 |
Likelihood low so decided against testing | 18 (6.6%) | 1 (1.9%) | 17 (7.8%) | 0.14 |
Genetic counseling
GC Requirement Policy | BRCA1/2 Testing | ||||||
---|---|---|---|---|---|---|---|
Total N (%) | Before N (%) | After N (%) | P-value | Tested N (%) | Not Tested N (%) | P-value | |
Received Genetic Counseling | |||||||
Total | n = 1247 | n = 297 | n = 940 | n = 966 | n = 271 | ||
Yes | 802 (64.3%) | 86 (28.9%) | 716 (75.5%) | < 0.0001 | 689 (71.3%) | 107 (39.5%) | < 0.0001 |
No | 389 (31.2%) | 193 (64.8%) | 196 (20.7%) | 243 (25.2%) | 144 (53.1%) | ||
Unknown | 40 (3.2%) | 12 (4.0%) | 28 (3.0%) | 27 (2.8%) | 12 (4.4%) | ||
Most Commonly Reported Reasons for Receiving Genetic Counselinga | |||||||
Total | n = 802 | n = 86 | n = 716 | n = 689 | n = 107 | ||
Insurance Requirement | 592 (73.8%) | 14 (16.3%) | 578 (80.7%) | < 0.0001 | 504 (73.1%) | 85 (79.4%) | 0.16 |
Chance to better Understand the Test Results | 246 (30.7%) | 41 (47.7%) | 205 (28.6%) | 0.0003 | 224 (32.5%) | 21 (19.6%) | 0.0054 |
Recommended by Doctor | 217 (27.1%) | 55 (64.0%) | 162 (22.6%) | < 0.0001 | 196 (28.4%) | 21 (19.6%) | 0.049 |
Most Commonly Reported Reasons for Not Receiving Genetic Counselinga | |||||||
Total | n = 389 | n = 193 | n = 196 | n = 243 | n = 144 | ||
Was not Aware GC was Available | 175 (45.1%) | 122 (63.2%) | 53 (27.2%) | < 0.0001 | 145 (59.9%) | 28 (19.4%) | < 0.0001 |
Insurance Issues/Requirements | 88 (22.6%) | 22 (11.4%) | 66 (33.7%) | < 0.0001 | 17 (7%) | 70 (48.6%) | < 0.0001 |
Inconvenience of Additional Step | 30 (7.7%) | 10 (5.2%) | 20 (10.3%) | 0.06 | 12 (5%) | 18 (12.5%) | 0.0087 |
Time Restraints | 29 (7.5%) | 5 (2.3%) | 24 (12.3%) | 0.0003 | 12 (5%) | 17 (11.8%) | 0.016 |
Not Interested in Pursuing | 24 (6.2%) | 14 (7.3%) | 10 (5.1%) | 0.38 | 16 (6.6%) | 8 (5.6%) | 0.68 |
Cost of Appointment | 23 (5.9%) | 7 (3.6%) | 16 (8.2%) | 0.06 | 4 (1.7%) | 19 (13.2%) | < 0.0001 |
Did you receive a benefit from genetic counseling? | |||||||
Total | n = 632 | n = 103 | n = 529 | n = 521 | n = 110 | ||
Yes | 503 (79.6%) | 80 (77.7%) | 423 (80.0%) | 0.60 | 438 (84.1%) | 64 (58.2%) | < 0.0001 |
No | 129 (20.4%) | 23 (22.3%) | 106 (20.0%) | 83 (15.9%) | 46 (41.8%) | ||
Would you recommend genetic counseling to family or friends? | |||||||
Total | n = 633 | n = 102 | n = 531 | n = 524 | n = 109 | ||
Yes | 574 (90.7%) | 99 (97.6%) | 475 (89.5%) | 0.014 | 479 (91.4%) | 95 (87.2%) | 0.18 |
No | 59 (9.3%) | 3 (2.9%) | 56 (10.6%) | 45 (8.6%) | 14 (12.8%) | ||
Would you utilize genetic counseling in the future? | |||||||
Total | n = 626 | n = 103 | n = 523 | n = 518 | n = 108 | ||
Yes | 548 (87.5%) | 95 (92.2%) | 453 (86.6%) | 0.10 | 454 (87.6%) | 94 (87.0%) | 0.86 |
No | 78 (12.5%) | 8 (7.8%) | 70 (13.4%) | 64 (12.4%) | 14 (13%) |